Panuveitis

Panuveitis is a kind of eye inflammation. It means the whole uvea is inflamed. The uvea is the “middle coat” of the eye. It has three main parts: the iris in the front, the ciliary body in the middle, and the choroid in the back. In panuveitis, all of these parts are affected at the same time. The inflammation can also spread to nearby tissues like the retina (the light-sensing layer), the vitreous gel inside the eye, the optic nerve, and sometimes even the sclera (the white of the eye). When these tissues are inflamed, they leak cells and proteins. This can make the eye red, painful, and blurry. It can also create floaters and light sensitivity. Panuveitis is a serious condition. It needs careful testing to find the cause. It also needs timely treatment to protect vision.

Panuveitis means inflammation across the entire uvea—the middle, living layer of the eye that includes the iris (the colored ring), ciliary body (the focusing muscle that also makes eye fluid), and choroid (the blood-rich layer that feeds the retina). In panuveitis, inflammation is not limited to the front or back—it is everywhere in the uvea. Because the uvea feeds and supports the retina and other eye parts, panuveitis can quickly affect vision, eye pressure, and comfort.

Think of the eye as a small, precise camera. If inflammation spreads throughout its middle layer, the whole camera misbehaves—focus goes off, the lens fogs, the film (retina) gets irritated, and the fluid flow in the camera changes. That is panuveitis.

---

What “panuveitis” means in simple words

• “Pan” means “all.”

• “Uveitis” means inflammation of the uvea.

• So panuveitis means inflammation of all parts of the uvea at once. It is different from anterior uveitis (front only), intermediate uveitis (middle), or posterior uveitis (back). In panuveitis the inflammation is widespread.

Inflammation is the body’s defense system turned on inside the eye. White blood cells move into the eye and release chemicals. These chemicals try to fight germs or clean up damage. But they also make tissue swollen and leaky. This swelling and leak block the clear path for light. That is why vision becomes cloudy or dim.

---

Why panuveitis matters

The eye is a small space that needs to stay clear. Even a small amount of inflammation can cause big vision changes. Panuveitis can raise eye pressure (secondary glaucoma). It can make the lens cloudy (cataract). It can cause swelling in the retina (macular edema) or scars in the back of the eye. These changes can be long-lasting if not treated. That is why finding the cause and controlling the inflammation early is so important.

---

Types of panuveitis

Doctors group panuveitis in a few helpful ways. These groups guide testing and treatment.

1. By cause

   • Infectious panuveitis. A germ such as a bacterium, virus, parasite, or fungus triggers the inflammation. Treating the germ is key.

   • Non-infectious (immune-mediated) panuveitis. The immune system attacks the eye by mistake, often as part of a body-wide disease (autoimmune disease).

   • Masquerade syndromes. A disease that is not true inflammation imitates panuveitis. An example is eye lymphoma (a cancer of immune cells inside the eye).

   • Trauma-related panuveitis. Injury or surgery can trigger widespread inflammation.

   • Drug-induced panuveitis. Rarely, a medicine triggers inflammation in the eye.

2. By time course

   • Acute. Starts suddenly and lasts less than 3 months.

   • Chronic. Lasts 3 months or more without stopping.

   • Recurrent. Gets better, then comes back again after a quiet period.

3. By appearance under the microscope

   • Granulomatous. Large immune cells cluster into small nodules. Doctors often see greasy-looking deposits on the back of the cornea called mutton-fat keratic precipitates. This pattern is common in sarcoidosis, tuberculosis, and some autoimmune diseases.

   • Non-granulomatous. The inflammation is more fine and diffuse. This pattern is common in HLA-B27 diseases and some viral causes.

4. By laterality

   • Unilateral. One eye is involved.

   • Bilateral. Both eyes are involved (either at the same time or one after the other). Many immune diseases affect both eyes.

5. By dominant tissue involvement (even though all are inflamed)

   • Retina-dominant panuveitis. Retinal swelling or vasculitis (inflamed blood vessels) stands out.

   • Choroid-dominant panuveitis. Choroidal spots and fluid under the retina stand out.

   • Vitreous-dominant panuveitis. Many cells and haze in the gel (vitreous) cause floaters and foggy vision.

6. By severity

   • Mild, moderate, or severe. Doctors grade the number of inflammatory cells and the haze level using standard uveitis scales. The grade helps track progress with treatment.

These type labels can overlap. A person might have chronic, bilateral, granulomatous, non-infectious panuveitis, for example. The labels help organize thinking and help choose the right tests.

---

Common causes of panuveitis

Important: Causes vary by country, age, and health history. Some causes are common in one place and rare in another. The list below covers major, widely taught causes.

Infectious causes (germs trigger the inflammation)

1. Tuberculosis (TB).
   TB bacteria can hide in the body for years. They can inflame the uvea by direct infection or by a strong immune reaction to TB proteins. Eye signs can be granulomatous with large corneal deposits and choroidal spots.

2. Syphilis.
   This bacterial infection can inflame almost any eye layer at any stage. It is called the “great imitator.” Testing is crucial because prompt antibiotics can protect vision.

3. Toxoplasmosis.
   A parasite from undercooked meat or cat feces can infect the retina and choroid. It often causes a white, fluffy retinal lesion with overlying vitreous haze (“headlight in the fog”). When widespread, it can look like panuveitis.

4. Herpes simplex virus (HSV).
   This virus can inflame the front and back of the eye. It can raise eye pressure and cause severe pain and light sensitivity. It may leave the cornea numb or scarred.

5. Varicella-zoster virus (VZV).
   This is the shingles virus. When it involves the eye, it can cause both anterior and posterior inflammation and retinal blood vessel problems. It is more severe in older adults or people with weaker immunity.

6. Cytomegalovirus (CMV).
   In people with weak immune systems, CMV can infect the retina and spread, causing widespread inflammation and bleeding. It needs urgent antiviral therapy.

7. Lyme disease.
   This tick-borne infection can inflame the uvea. It may come with a history of tick bite, rash, joint pain, or nerve symptoms. It is uncommon in many regions but should be considered in the right setting.

8. Leptospirosis.
   This water-borne bacterial infection can inflame many organs, including the eyes. Eye findings include panuveitis with vitritis (cells in the gel) and retinal vessel problems.

9. Endogenous fungal infection (e.g., Candida).
   Fungi from the bloodstream can seed the eye, especially in people with bloodstream infections, indwelling lines, IV drug use, or after major surgery. It often presents with white, fluffy lesions and marked vitritis.

10. Post-surgical or post-traumatic endophthalmitis.
    After eye surgery or a penetrating injury, bacteria can enter the eye. This causes intense panuveitis-like inflammation with pain, redness, and severe vision loss. It is an emergency.

Non-infectious and immune-mediated causes

11. Sarcoidosis.
    Sarcoid forms granulomas in many organs, including the eye. It can cause mutton-fat deposits, iris nodules, and choroidal lesions. Chest imaging and blood tests (like ACE) can aid diagnosis.

12. Behçet disease.
    This is an inflammatory blood vessel disease. It causes mouth and genital ulcers, skin lesions, and eye inflammation with retinal vasculitis. Eye attacks can be sudden and severe.

13. Vogt-Koyanagi-Harada (VKH) disease.
    The immune system attacks melanocyte-rich tissues like the uvea, skin, hair, and inner ear. It often causes both-eye panuveitis with fluid under the retina, headache, hearing changes, and skin/hair color changes.

14. Sympathetic ophthalmia.
    After one eye is badly injured or operated on, the immune system can later attack the other eye. Both eyes become inflamed. It is rare but serious.

15. HLA-B27–associated disease (e.g., ankylosing spondylitis, reactive arthritis, psoriatic arthritis, IBD-related arthritis).
    These conditions can cause uveitis that is often sudden and painful. Although classic HLA-B27 uveitis is anterior, it can extend and present as panuveitis.

16. Birdshot chorioretinopathy (HLA-A29–associated).
    This is a chronic, bilateral chorioretinal inflammation with cream-colored spots in the back of the eye and significant vitreous cells. It is tightly linked to HLA-A29.

17. Systemic lupus erythematosus (SLE).
    Lupus can inflame the eye’s blood vessels and the uvea. It often presents with other body signs like joint pain, rashes, and kidney issues.

18. Granulomatosis with polyangiitis (GPA, formerly Wegener).
    This is a small-vessel vasculitis that can inflame the eye and the orbit. It can cause scleritis (deep eye wall inflammation) plus uveitis.

19. Drug-induced uveitis.
    Rarely, medications such as certain antibiotics (e.g., rifabutin), bisphosphonates, immune checkpoint inhibitors, and others can trigger uveitis. Stopping the drug and treating the inflammation are key steps.

20. Intraocular lymphoma (masquerade).
    This cancer of immune cells inside the eye can mimic chronic panuveitis. It may respond poorly to steroids or relapse when steroids are reduced. Diagnosis can require sampling the eye fluid for special tests.

---

Common symptoms

1. Blurred vision.
   Vision looks foggy or smeared, like looking through a dirty window.

2. Eye pain or aching.
   The eye feels sore or deep aching. Pain can worsen with light or focusing.

3. Red eye.
   Blood vessels on the white of the eye look bright red or pink.

4. Light sensitivity (photophobia).
   Light hurts the eyes. People may squint or avoid bright rooms.

5. Floaters.
   Small dark spots, threads, or cobwebs drift across vision due to cells and debris in the vitreous gel.

6. Decreased central vision.
   Fine detail seems lost. Reading and face recognition become harder.

7. Distorted vision (metamorphopsia).
   Straight lines look wavy. Boxes look bent. This suggests macular swelling.

8. Color fading.
   Colors look less bright or washed out, especially reds.

9. Patchy missing areas (scotomas).
   There are small blind spots or gray areas in the field of view.

10. Poor night vision.
    Dim light feels very hard. Glare from headlights is bothersome.

11. Halos or rainbow rings.
    People may see colored rings around lights if the cornea is swollen or if eye pressure is high.

12. Headache.
    A dull ache can spread from the eye to the forehead or temple.

13. Tearing or watery eyes.
    The eyes water more than normal. This does not mean infection by itself.

14. Small or irregular pupil.
    The pupil may look smaller or oddly shaped due to muscle spasm or thin adhesions.

15. Eyelid heaviness or swelling feeling.
    The eye can feel “full” or pressured even if the lids look normal.

Urgent signs: Sudden severe pain, a big drop in vision, or many new floaters and flashes are warning signs. These deserve same-day eye care.

---

Diagnostic tests

A) Physical exam and simple in-office checks

1. Visual acuity (eye chart).
   What: Reading letters at a set distance.
   Why: Measures how much central vision is reduced.
   Shows: Degree of blur; tracks improvement with treatment.

2. Pupil exam (light reflex and RAPD check).
   What: Shining a light to see how pupils react and comparing both eyes.
   Why: Finds optic nerve stress or severe retinal damage.
   Shows: A “relative afferent pupillary defect” (RAPD) if one eye’s pathway is weaker.

3. Color vision testing (e.g., simple plates).
   What: Identifying colored dots or numbers.
   Why: Sensitive to macular or optic nerve problems.
   Shows: Color desaturation common in inflammation affecting the macula or nerve.

4. Confrontation visual fields.
   What: Comparing a patient’s side vision to the examiner’s by wiggling fingers in the periphery.
   Why: Screens for missing areas of vision.
   Shows: Patchy field loss from retinal or nerve involvement.

5. Amsler grid.
   What: A small square grid held at reading distance.
   Why: Detects warping or missing spots in central vision.
   Shows: Distortion from macular edema or scars.

B) Manual ophthalmic tests (hands-on, slit-lamp–based, in clinic)

6. Slit-lamp biomicroscopy with cell/flare grading.
   What: A microscope lets the doctor see the front of the eye and the aqueous fluid beam.
   Why: Counts inflammatory cells and protein “flare” using standard uveitis grading.
   Shows: Keratic precipitates (deposits), iris nodules, adhesions, and activity level.

7. Intraocular pressure measurement (applanation tonometry).
   What: A gentle probe measures eye pressure.
   Why: Inflammation or steroid treatment can raise pressure.
   Shows: High pressure (secondary glaucoma) or, less often, low pressure.

8. Gonioscopy.
   What: A special mirrored lens examines the drainage angle.
   Why: Finds inflammatory debris, angle closure, or new blood vessels.
   Shows: Risk of pressure spikes and need for pressure-lowering care.

9. Dilated indirect ophthalmoscopy (fundus exam).
   What: Dilating drops plus lenses let the doctor view the vitreous, retina, and choroid.
   Why: Essential for panuveitis because back-of-eye changes drive vision.
   Shows: Vitreous cells/haze, retinal vasculitis, choroidal lesions, edema, hemorrhage.

10. Vitreous haze grading (standard uveitis scale).
    What: The doctor grades how cloudy the vitreous gel is.
    Why: Haze level tracks how much inflammation is inside the eye.
    Shows: Baseline severity and response to treatment over time.

C) Lab and pathological tests (blood or eye-fluid–based)

11. Complete blood count (CBC) plus ESR/CRP.
    What: Blood tests for infection and inflammation levels.
    Why: Not specific but points to active inflammation or infection.
    Shows: Elevated white cells, anemia, platelet changes; high ESR/CRP in active disease.

12. Syphilis serology (non-treponemal + treponemal tests).
    What: Two-step blood testing (e.g., RPR/VDRL and TPPA/FTA-ABS).
    Why: Syphilis can mimic any uveitis; always check for it.
    Shows: Current or past infection that needs antibiotic therapy.

13. Tuberculosis screening (IGRA or PPD).
    What: Blood interferon-gamma release assay (IGRA) or skin test (PPD).
    Why: TB-related uveitis requires TB treatment.
    Shows: Prior exposure or latent infection; guides further chest imaging and referral.

14. Sarcoid markers (ACE, lysozyme) and serum calcium.
    What: Blood tests that can be elevated in sarcoidosis.
    Why: Support the diagnosis with clinical signs and imaging.
    Shows: A pattern compatible with sarcoid, though not proof by themselves.

15. Toxoplasma testing and ocular fluid PCR when needed.
    What: Blood antibodies and, if needed, PCR on a small eye-fluid sample.
    Why: Helps confirm parasite-related inflammation.
    Shows: Active infection evidence requiring anti-parasitic therapy.

D) Electrodiagnostic tests (how the retina and nerve carry signals)

16. Full-field electroretinogram (ERG).
    What: Measures the electrical response of the whole retina to flashes of light.
    Why: Shows if retinal cells are functioning and how much.
    Shows: Reduced responses in widespread retinal inflammation or damage.

17. Visual evoked potential (VEP).
    What: Measures the brain’s response to visual signals from the eyes.
    Why: Assesses the optic nerve pathway.
    Shows: Delayed or weak signals when the nerve is inflamed or stressed.

E) Imaging tests (pictures of eye structure and blood flow)

18. Optical coherence tomography (OCT).
    What: A scan that slices the retina into layers using light.
    Why: Detects swelling, fluid, and structural changes with high detail.
    Shows: Macular edema, subretinal fluid (common in VKH), and retinal thinning or scars.

19. Fluorescein angiography (FA/FFA).
    What: A dye is injected into a vein; a special camera tracks the dye in retinal vessels.
    Why: Shows leaking vessels and inflamed areas.
    Shows: Retinal vasculitis, ischemia, macular leakage, and treatment targets.

20. Indocyanine green angiography (ICGA).
    What: A different dye highlights the deeper choroidal circulation.
    Why: Excellent for choroidal inflammation patterns.
    Shows: Hidden choroidal lesions and leakage not visible on fluorescein.

Non-pharmacological treatments

Below are 20 practical, non-drug steps. For each: Description — Purpose — Mechanism (how it helps).

1. Urgent specialist follow-up plan
   Description: Get a same-day or next-day appointment if new symptoms appear; keep scheduled reviews.
   Purpose: Catch inflammation early and adjust therapy quickly.
   Mechanism: Frequent checks (vision, pressure, retina) let your doctor tweak drops/injections before damage occurs.

2. Light control and sunglasses
   Description: Wear dark, quality sunglasses and use dimmer indoor lighting during flares.
   Purpose: Reduce light sensitivity (photophobia) and eye strain.
   Mechanism: Limits incoming light that irritates an already inflamed iris and retina.

3. Screen hygiene (20-20-20 rule)
   Description: Every 20 minutes, look 20 feet away for 20 seconds.
   Purpose: Ease focusing muscle spasm and dryness during screen time.
   Mechanism: Relaxes the ciliary body and reduces surface dryness that worsens discomfort.

4. Contact-lens holiday
   Description: Stop contact lenses during active inflammation.
   Purpose: Reduce irritation and infection risk.
   Mechanism: Lenses can rub the cornea and trap debris; stopping them calms the surface.

5. Cold compress for comfort
   Description: Apply a clean, cool compress gently over closed lids for 5–10 minutes.
   Purpose: Soothe pain and light sensitivity.
   Mechanism: Mild cooling reduces local blood flow and inflammatory signaling.

6. Protective eyewear
   Description: Use safety glasses during sports, DIY, or dusty environments.
   Purpose: Prevent trauma that can trigger or worsen inflammation.
   Mechanism: Physical barrier protects the eye from hits and particles.

7. Drop-instillation coaching
   Description: Learn proper technique (wash hands, avoid touching the tip, punctal occlusion).
   Purpose: Make each drop count and limit side effects.
   Mechanism: Correct placement increases drug staying time; pressing the tear duct reduces systemic absorption.

8. Smoking cessation
   Description: Quit smoking; avoid secondhand smoke.
   Purpose: Lower flare risk and improve treatment success.
   Mechanism: Smoke drives systemic inflammation and damages micro-vessels that feed eye tissues.

9. Sleep optimization
   Description: 7–9 hours of regular, high-quality sleep.
   Purpose: Support immune balance and healing.
   Mechanism: Sleep tunes inflammatory and hormonal signals that influence autoimmunity.

10. Stress-reduction training
    Description: Mindfulness, breathing exercises, yoga, or CBT.
    Purpose: Reduce stress-induced flares.
    Mechanism: Stress hormones (like cortisol surges) can push immune imbalance; training blunts that cycle.

11. Graded physical activity
    Description: Low-impact exercise (walking, cycling, swimming) most days.
    Purpose: Improve overall inflammation and mood.
    Mechanism: Exercise shifts cytokines toward an anti-inflammatory pattern and supports vascular health.

12. Anti-inflammatory eating pattern
    Description: More vegetables, fruit, legumes, whole grains, fish; fewer ultra-processed foods.
    Purpose: Reduce background inflammation and support retinal health.
    Mechanism: Fiber, omega-3s, polyphenols, and micronutrients modulate immune pathways and oxidative stress.

13. Hydration and alcohol moderation
    Description: Drink water regularly; limit alcohol.
    Purpose: Support tear film and systemic balance.
    Mechanism: Good hydration stabilizes ocular surface; excess alcohol can worsen inflammation and drug side effects.

14. Oral/dental and sinus health
    Description: Keep gums and sinuses healthy; treat infections promptly.
    Purpose: Reduce systemic inflammatory load and infection-related triggers.
    Mechanism: Chronic oral/sinus inflammation can feed immune activation that spills over to the eye.

15. Vaccination planning (with your doctors)
    Description: Review vaccine status before strong immunosuppression.
    Purpose: Lower risk of preventable infections during therapy.
    Mechanism: Appropriate non-live vaccines reduce infection triggers without worsening uveitis.

16. Infection screening and prevention habits
    Description: Safe sex, TB risk review, food/water safety in travel.
    Purpose: Prevent infectious uveitis.
    Mechanism: Reduces exposure to pathogens like syphilis, TB, and toxoplasma.

17. Coordinate care with rheumatology/infectious disease
    Description: Joint management plan if systemic disease or infection is present.
    Purpose: Treat the root cause and align drug choices.
    Mechanism: Systemic control calms eye inflammation more reliably.

18. Symptom diary and flare triggers
    Description: Track pain, light sensitivity, floaters, stress, sleep, diet changes.
    Purpose: Spot personal patterns and respond sooner.
    Mechanism: Early warning allows pre-emptive adjustments.

19. Driving and safety precautions
    Description: Avoid driving during flares or at night if vision is reduced.
    Purpose: Prevent accidents.
    Mechanism: Inflammation affects contrast, glare, and reaction time.

20. Workplace/academic accommodations
    Description: Request screen breaks, larger fonts, glare filters.
    Purpose: Maintain productivity without worsening symptoms.
    Mechanism: Reduces eye strain while healing continues.

---

Drug treatments

(Typical adult regimens shown; exact dosing/timing must be individualized by your ophthalmologist. Children, pregnancy, kidney/liver disease, infections, and drug interactions require specialist judgment.)

1. Topical corticosteroid (Prednisolone acetate 1% eye drops)
   Class: Corticosteroid (topical).
   Dosage/Time: From every hour while awake in severe flares, then taper to several times/day as inflammation quiets.
   Purpose: First-line to quickly reduce anterior segment inflammation (helps overall comfort in panuveitis).
   Mechanism: Blocks many inflammatory pathways (NF-κB, cytokines).
   Side effects: High eye pressure, cataract with prolonged use, infection risk, stinging.

2. Cycloplegic/mydriatic (Atropine 1% or Cyclopentolate 1%)
   Class: Antimuscarinic.
   Dosage/Time: Atropine 1% 1–2×/day; or Cyclopentolate 1% 2–3×/day during flare.
   Purpose: Pain relief and prevention of iris sticking to lens (synechiae).
   Mechanism: Temporarily paralyzes the ciliary muscle and dilates the pupil, calming spasm and keeping structures apart.
   Side effects: Blurry near vision, light sensitivity, dry mouth; rare systemic effects in children.

3. Oral corticosteroid (Prednisone)
   Class: Systemic corticosteroid.
   Dosage/Time: Often 0.5–1 mg/kg/day initially, then taper over weeks based on response; severe cases may need IV methylprednisolone pulses.
   Purpose: Rapid, whole-eye inflammation control.
   Mechanism: Potent suppression of inflammatory gene transcription.
   Side effects: Weight gain, mood changes, high blood sugar, high blood pressure, bone loss, infection risk; requires careful taper.

4. Periocular or intravitreal steroid (Triamcinolone acetonide)
   Class: Corticosteroid injection.
   Dosage/Time: Periocular 40 mg/mL depot; intravitreal doses vary by product; lasts weeks to months.
   Purpose: Local control of severe eye inflammation or macular edema when drops are not enough.
   Mechanism: High local steroid levels directly reduce retinal/uveal inflammation.
   Side effects: Eye pressure spikes, cataract, rare infection.

5. Intravitreal steroid implants (Dexamethasone 0.7 mg / Fluocinolone 0.18–0.59 mg)
   Class: Long-acting corticosteroid devices.
   Dosage/Time: Single in-office implant; dexamethasone lasts ~3–6 months; fluocinolone lasts up to 3 years (product-dependent).
   Purpose: Long-term control, especially for chronic, relapsing noninfectious panuveitis or macular edema.
   Mechanism: Sustained steroid release within the eye.
   Side effects: Cataract, high pressure requiring drops or surgery, rare implant-related issues.

6. Methotrexate
   Class: Antimetabolite immunomodulator (csDMARD).
   Dosage/Time: 10–25 mg once weekly by mouth or subcutaneous; plus folic acid (commonly 1 mg daily).
   Purpose: Steroid-sparing long-term control of noninfectious uveitis.
   Mechanism: Low-dose anti-inflammatory effects (adenosine pathway modulation).
   Side effects: Nausea, mouth sores, liver enzyme rise, low blood counts (monitor labs); avoid in pregnancy.

7. Mycophenolate mofetil
   Class: Antimetabolite (IMDH inhibitor).
   Dosage/Time: 1,000–1,500 mg twice daily.
   Purpose: Another common steroid-sparing agent.
   Mechanism: Selectively limits lymphocyte proliferation.
   Side effects: GI upset, infections, low white cells; strict pregnancy precautions.

8. Azathioprine
   Class: Antimetabolite.
   Dosage/Time: Typically 1–2.5 mg/kg/day; check TPMT/NUDT15 status if available.
   Purpose: Maintenance control when methotrexate or mycophenolate are unsuitable.
   Mechanism: Reduces lymphocyte DNA synthesis.
   Side effects: Bone-marrow suppression, liver enzyme rise, infection risk.

9. Calcineurin inhibitors (Cyclosporine or Tacrolimus)
   Class: T-cell inhibitors.
   Dosage/Time: Cyclosporine ~2–5 mg/kg/day; Tacrolimus ~0.05–0.15 mg/kg/day in divided doses (blood-level monitoring).
   Purpose: Steroid-sparing or add-on control for refractory disease.
   Mechanism: Blocks T-cell activation (IL-2 pathway).
   Side effects: Kidney effects, high blood pressure, tremor; drug interactions.

10. Adalimumab
    Class: Anti-TNF-α biologic (FDA-approved for noninfectious intermediate, posterior, and panuveitis).
    Dosage/Time: 80 mg once, then 40 mg at week 1, then 40 mg every 2 weeks (maintenance); pediatric dosing is weight-based.
    Purpose: Control and prevent flares, reduce steroid dependence.
    Mechanism: Neutralizes TNF-α, a key inflammation driver.
    Side effects: Infection risk (screen for TB/hepatitis), injection reactions; rare demyelination or lupus-like syndrome.

Important: If panuveitis is infectious, the plan changes—you need the right antibiotic/antiviral/antiparasitic first (sometimes alongside careful steroids). That choice depends on tests (e.g., syphilis, TB, toxoplasma, herpes).

---

Dietary molecular supplements

(Discuss with your clinicians; supplements can interact with medicines. Doses are typical adult ranges, not personal prescriptions.)

1. Omega-3s (EPA/DHA) — 1–3 g/day combined EPA+DHA
   Function: General anti-inflammatory support; may help macular health.
   Mechanism: Compete with omega-6 pathways and generate pro-resolving mediators.

2. Vitamin D3 — 1,000–2,000 IU/day (more if deficient, per labs)
   Function: Immune modulation; deficiency is common.
   Mechanism: Nuclear receptor signaling that calms autoimmune activity.

3. Curcumin (with piperine or enhanced formulation) — 500–1000 mg 1–2×/day
   Function: Adjunct anti-inflammatory/antioxidant.
   Mechanism: Inhibits NF-κB and inflammatory cytokines.

4. Lutein + Zeaxanthin — 10 mg + 2 mg/day
   Function: Macular pigment support and antioxidant defense.
   Mechanism: Filters blue light and quenches retinal oxidative stress.

5. N-Acetylcysteine (NAC) — 600 mg 1–2×/day
   Function: Antioxidant and mucus/tear support.
   Mechanism: Glutathione precursor; reduces oxidative signaling.

6. Quercetin — 500 mg 1–2×/day
   Function: Anti-inflammatory flavonoid adjunct.
   Mechanism: Modulates mast cells and cytokines.

7. Resveratrol — 150–300 mg/day
   Function: Anti-oxidative, may aid vascular health.
   Mechanism: SIRT1 activation and cytokine modulation.

8. Coenzyme Q10 — 100–200 mg/day
   Function: Mitochondrial antioxidant support for retinal cells.
   Mechanism: Electron transport and reactive oxygen species control.

9. Probiotics (multi-strain) — ≥10^9 CFU/day
   Function: Gut–immune axis balance.
   Mechanism: Alters gut microbiome, which can shape systemic immune tone.

10. Folic acid (with methotrexate) — ~1 mg/day or 5 mg once weekly (per doctor)
    Function: Reduces methotrexate side effects without weakening control.
    Mechanism: Replenishes folate stores affected by low-dose MTX.

---

Advanced” immune-rebalancing therapies

There are no approved “stem-cell drugs” for panuveitis. Cell-based therapies are experimental and done only in clinical trials. The following advanced medicines are used by specialists when disease is severe or relapsing.

1. Infliximab
   Dosage: 5–10 mg/kg IV at weeks 0, 2, 6, then every 4–8 weeks.
   Function: Strong control of refractory noninfectious uveitis (notably Behçet).
   Mechanism: Anti-TNF-α monoclonal antibody.
   Key cautions: TB/hepatitis screening; infusion reactions; infection risk.

2. Tocilizumab
   Dosage: 8 mg/kg IV every 4 weeks or 162 mg SC every 1–2 weeks (protocol varies).
   Function: Helps resistant macular edema and uveitis when anti-TNF fails.
   Mechanism: Blocks IL-6 receptor signaling.
   Key cautions: Infections, liver enzymes, lipids; monitor labs.

3. Rituximab
   Dosage: 1,000 mg IV on days 1 and 15, or 375 mg/m² weekly × 4 (regimens vary).
   Function: Useful in select autoimmune uveitides with B-cell involvement.
   Mechanism: Depletes CD20-positive B cells.
   Key cautions: Infusion reactions, infections; screen for hepatitis B.

4. Interferon-α2a
   Dosage: Commonly 3–6 million IU SC several times per week, adjusted by response.
   Function: Often effective in Behçet uveitis to reduce flares.
   Mechanism: Immunomodulation (antiviral/antiproliferative signaling).
   Key cautions: Flu-like symptoms, mood changes, thyroid changes.

5. Tofacitinib (JAK inhibitor)
   Dosage: 5 mg orally twice daily (protocols vary; off-label).
   Function: Option in refractory cases after other agents.
   Mechanism: Blocks JAK-STAT pathways for multiple cytokines.
   Key cautions: Infection, lipids, clot risk; careful selection and monitoring.

6. Sirolimus (local or systemic; some formulations intravitreal)
   Dosage: Systemic: trough-guided oral dosing; Intravitreal: product-specific dosing by retina specialist.
   Function: Steroid-sparing control in select chronic cases.
   Mechanism: mTOR inhibition dampens T-cell activity.
   Key cautions: Mouth ulcers, lipids, wound healing delay, infection risk.

About stem cells: Autologous hematopoietic or mesenchymal stem cell therapies are investigational for severe autoimmune disease and are not routine care for uveitis. Risks are significant and these should only be considered in controlled trials.

---

Surgeries

1. Pars plana vitrectomy (PPV)
   Procedure: A retina surgeon removes the inflamed vitreous gel through tiny ports.
   Why: To clear dense floaters or debris, sample for infection/cancer, reduce inflammatory load, treat traction or hemorrhage.

2. Intravitreal steroid implant placement (Ozurdex®, Yutiq®, Retisert®)
   Procedure: A small device is inserted in the eye in clinic or OR.
   Why: Provides long-term, steady steroid delivery when drops and pills are not enough or not tolerated.

3. Cataract surgery with IOL (phacoemulsification)
   Procedure: Clouded lens is removed and replaced with a clear artificial lens.
   Why: Long-standing inflammation or steroids can cause cataract that blurs vision; surgery restores clarity (with careful inflammation control before/after).

4. Glaucoma surgery (trabeculectomy or tube shunt)
   Procedure: Creates a new drainage pathway for eye fluid.
   Why: Uveitis or steroids can raise eye pressure; when drops fail, surgery protects the optic nerve.

5. Synechiolysis/membranectomy ± peripheral iridotomy
   Procedure: Breaks scar tissue that sticks the iris to the lens or blocks fluid flow; may add a small opening in the iris.
   Why: Restores pupil shape and aqueous flow, improving vision and pressure.

---

Prevention tips

1. Treat and monitor systemic autoimmune disease with the right specialists.

2. Screen for infections (e.g., TB, syphilis) when advised, and complete treatment.

3. Vaccinations up to date before strong immunosuppression (avoid live vaccines once immunosuppressed).

4. Quit smoking; avoid secondhand smoke.

5. Practice safe sex and get regular STI screening if at risk.

6. Use eye protection in sports/DIY to prevent trauma-triggered flares.

7. Keep dental/sinus health in check to reduce chronic inflammatory load.

8. Maintain anti-inflammatory eating and regular exercise.

9. Adhere to treatment and never stop steroids suddenly without a taper plan.

10. Arrange regular eye exams, especially if you have a known risk condition.

---

When to see a doctor (or the ER)

• Same-day/urgent: New eye pain, severe light sensitivity, sudden floaters or “smoke,” new blurry vision, halos, shadows, or a curtain in vision.

• Right away if on immunosuppressants and you develop fever, cough, sores, or exposure to TB.

• Immediately after eye injury or surgery if symptoms flare.

• Promptly in pregnancy if you have uveitis—plans may change for safety.

• Routine visits even when well, because quiet eyes can still need monitoring.

---

What to eat” and “what to avoid”

(Food complements—not replaces—medical care.)

1. Eat: Fatty fish (salmon, sardines) 2–3×/week for omega-3s.

2. Eat: Leafy greens (spinach, kale) for lutein/zeaxanthin.

3. Eat: Colorful fruits/berries for antioxidants.

4. Eat: Nuts/seeds (walnuts, flax, chia) for healthy fats and minerals.

5. Eat: Spices like turmeric/ginger in meals for natural anti-inflammatory support.

6. Eat: Fermented foods (yogurt/kefir) for the gut–immune axis.

7. Avoid: Ultra-processed foods high in additives and trans fats.

8. Avoid: Sugary drinks and heavy refined sugars (they spike inflammation).

9. Avoid: Excess alcohol (increases side effects with many meds).

10. Avoid: Very salty, highly processed snacks (worsen blood pressure/edema).

---

Frequently Asked Questions

1) Is panuveitis an emergency?
It can be. If symptoms start quickly or vision changes, treat it like urgent. Early care saves sight.

2) Can panuveitis be cured?
Some cases resolve and never return. Others are chronic but controllable. The goal is long periods with no inflammation and no vision damage.

3) Is it contagious?
Panuveitis itself is not contagious. But if it is caused by an infection (like syphilis or TB), that infection can be contagious and must be treated and contained properly.

4) Why do I need so many tests?
Because the treatment depends on the cause. Autoimmune uveitis and infectious uveitis look similar but need very different drugs.

5) Will I go blind?
Most people do not if they get fast, proper treatment and follow-up. Delays and repeated flares increase risk.

6) Why are steroids used if they have side effects?
Steroids switch off inflammation quickly, protecting vision. Doctors then add steroid-sparing medicines to lower long-term steroid exposure.

7) How long will treatment last?
Acute flares may calm in weeks, but maintenance can last months to years to prevent relapse. Your plan is personalized.

8) Do biologics mean my disease is severe?
Biologics are used when disease is moderate to severe or keeps returning. They can reduce flares and steroid needs. They’re not “failure,” they’re a strong tool.

9) Can I use contact lenses again?
Yes—after the eye is quiet and your doctor approves. Many people restart with daily disposables and strict hygiene.

10) Can I work out?
Yes. Choose low-impact exercise during flares and build up slowly. Movement helps whole-body inflammation.

11) Are supplements necessary?
Not always. Food first. Some people benefit from omega-3, vitamin D, curcumin, etc. Always review supplements with your doctor to avoid interactions.

12) What about pregnancy?
Some medicines are unsafe in pregnancy; others are acceptable. Tell your doctor if you are pregnant or planning—your plan will change to protect you and the baby.

13) Do I need to change my diet drastically?
Small, steady changes help: more plants and fish, fewer processed foods and sugars. Diet supports your medicines; it does not replace them.

14) Can stress really trigger flares?
For many people, yes. Building a stress-reduction routine (sleep, breathing, mindfulness) is worthwhile.

15) What follow-up schedule should I expect?
During flares: frequent visits (weekly or biweekly). When quiet: every 1–3 months, then less often, depending on stability and treatment.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 19, 2025.